Erik Torenberg

Andy Jassy × Ben Horowitz × Erik Torenberg

Amazon expects about $220 billion of 2026 CapEx, yet AWS capacity is sold out for 2026, largely for 2027, and partly for 2028; AWS AI has exceeded a $25 billion revenue run rate.Data centers require investment roughly two years before monetization, pressuring free cash flow; broader enterprise inference adoption also hinges on costs Jassy still calls an order of magnitude too high.

Marc Andreessen × Ben Horowitz × Chris Dixon × Erik Torenberg

a16z is expanding the ACC Crypto Fund into a16z Frontier for “outer planets” beyond existing verticals as crypto’s boundaries blur with fintech and Wall Street.Marc Andreessen calls AI’s early-adopter gap with incumbents the widest of his career; employees adopting ahead of companies could fuel startup formation, while AI answers and Stack Overflow’s traffic drop point to an internet-economics reset.

Ben Horowitz × Martin Casado × Raghu Raghuram × Erik Torenberg

a16z’s new AI infrastructure fund captures a founder migration into hardware, with top-founder hardware pitches rising from roughly 3–5% to “north of 20% or 30%.”Hyperscaler capex, booked-out GPUs and resale premiums support opportunities across chips, power and cooling, while grid shortages, regulation and uncontrolled agent spending remain constraints.

Erik Torenberg × Benedict Evans

Agentic coding has crossed unmistakable product-market fit, with customers pulling products from vendors’ hands.Foundation models appear headed toward commodity economics absent durable differentiation, while today’s token scarcity meets $1 trillion–$2 trillion of capex and “100x, 200x” efficiency gains.Cheaper development should create more software, but the unresolved question is which SaaS incumbents survive and whether models capture infrastructure-like returns.

Alex Rampell × Erik Torenberg × Mike Cannon-Brookes

AI is repricing SaaS before proving universal impairment, with Zendesk-like seat models exposed to agent substitution while Workday’s employee-based pricing and Adobe’s middle position may be underappreciated.Atlassian’s three great quarters, accumulated process knowledge, Teamwork Graph and extensibility strategy could make core systems stickier, but value depends on fair pricing and product design that earns trust as agents enter workflows.

Marc Andreessen × Erik Torenberg

Andreessen sees AI three years into an 80-year revolution, with customer revenue validating unusually rapid adoption across an already-built global distribution network.Falling token costs, competing chips, smaller models, and US-China rivalry could expand demand dramatically, while state regulation remains a major unresolved risk.

Erik Torenberg × Nathan Labenz × Zvi Moshowitz × Greg × Eugenia Kuyda × Ali Behrouz × Logan Kirkpatrick × Jungwon Hwang

AI’s strongest proof point is its performance alongside Nathan Labenz’s son’s oncologists, with minimal residual disease below one cell per million after remission before round two.Claude Opus 4.5 may be software AGI, but jagged failures and holiday hype leave full AGI unresolved, while context management, multi-model judgment, and infrastructure financing remain key risks.

Benedict Evans × Erik Torenberg

Generative AI may match the internet or smartphones in scale, but uneven adoption—ChatGPT’s 800 or 900 million weekly users with only about 5% paying—makes workflow integration, not model novelty, the central commercial test.Specialized products that encode validation and institutional knowledge may capture value above increasingly comparable models, while OpenAI’s distribution remains a fragile moat and falling compute costs, overbuilding and uncertain capability keep the bubble’s timing and infrastructure demand unresolved.

Erik Torenberg × Patrick Hsu × Jorge Conde

Arc is combining neuroscience, immunology, machine learning, chemical biology, and genomics to reduce organizational and experimental latency, with virtual cells aimed at navigating diseased cells toward healthy states.The commercial prize depends on better targets, drug design, higher clinical success, lower capital intensity, and shorter timelines, but physical testing and human endpoints remain serial bottlenecks while virtual-cell capability sits somewhere between GPT-1 and GPT-2.

Erik Torenberg × Martín Casado × Leo Polovets

Martín Casado argues that ignoring consensus is dangerous because early venture markets are “pretty darn efficient,” while a startup dependent on follow-on capital must eventually become fundable.The highest-alpha bets may begin outside consensus and then reprice sharply, but rapid markups can create fragility; the unresolved test is whether high-priced winners actually produce superior venture returns or merely reflect price arbitrage.